NFKB1 and type 2 diabetes mellitus: In conclusion, the NF-κB inhibitor celastrol provided a protective effect against target organ damage in type 2 diabetic mice through improved metabolic alterations as well as inhibition of profibrotic and proinflammatory processes in the target organs.